Preventing prostate cancer and adverse outcomes

Presenter: Dr. Robert Hamilton
Original Date: Tuesday, August 9, 2016

Overview:
  • General trends in prostate cancer
  • Risk factors for prostate cancer
  • Chemoprevention of prostate cancer
  • Statins and Metformin in preventing prostate cancer
  • Predicting future behaviour of prostate cancer and potential ways to inhibit bad behaviour

Dr. Robert Hamilton's Biography:

Dr. Robert Hamilton is a uro-oncologic surgeon specializing in prostate cancer. He has expertise in minimally invasive surgeries, including robotic surgery.  Dr. Hamilton sees patients at all different stages of prostate cancer from those at risk to this with early diagnoses to advanced disease.  His research interests in prostate cancer include the study of statins and metformin in prostate cancer prevention; whether genetic markers can be used to predict who will benefit from chemoprevention; and biomarkers of prostate cancer aggressiveness.

Expert Angle
About Expert Angle

Expert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
 
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.

   

Prostate Cancer Awareness Month

Donate Now!


Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More

Prostate Cancer Canada launches first national program in radionuclide therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.
More

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.
More


Click here for news archive